Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbCellera Biologics

2.45
+0.03001.24%
Post-market: 2.490.0400+1.63%19:09 EDT
Volume:4.39M
Turnover:10.74M
Market Cap:730.07M
PE:-4.43
High:2.49
Open:2.31
Low:2.31
Close:2.42
Loading ...
Feb 27, 2025

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 27, 2025

Major Issues Report

Form 8-K - Current report
Feb 19, 2025

Major Issues Report

Form 8-K - Current report
Nov 15, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Nov 04, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 04, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Aug 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Jun 13, 2024

Major Issues Report

Form 8-K - Current report
May 07, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
May 07, 2024

Major Issues Report

Form 8-K - Current report
Feb 23, 2024

Major Issues Report

Form 8-K - Current report
Feb 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Feb 20, 2024

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 20, 2024

Major Issues Report

Form 8-K - Current report
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024

Beneficial Ownership Change

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
Nov 29, 2023

Major Issues Report

Form 8-K - Current report
Nov 02, 2023

Major Issues Report

Form 8-K - Current report